It elucidated the mechanism by which BPNMs act as an effective PLK1 inhibitor for cancer chemotherapy and offered a practical solution for targeted cancer treatment using myeloid cell membrane‐coated BPNMs. The gene discussed is PLK1; the disease is cancer.